Tuberculosis pulmonar y principales factores prevalentes en una cohorte de pacientes latinoamericanos
DOI:
https://doi.org/10.55717/OSXX2169Palabras clave:
Mycobacterium tuberculosis, epidemiologia, factores sociodemográficos, factores de riesgo, infección tuberculosa latenteResumen
Esta investigación persiguió realizar un estudio descriptivo sobre la prevalencia de los factores de riesgo más frecuentes para tuberculosis pulmonar en una población latinoamericana. Se analizaron los factores sociodemográficos básicos y las características clínicas de 103 pacientes. Las variables categóricas se compararon mediante la prueba de chi-cuadrado; y analizaron mediante una regresión logística para evaluar su asociación. Como resultados, se identificó que la población de estudio tenía, al menos, una comorbilidad no transmisible. El grupo etario más afectado fue el de 18-34 años (57 %). Se diagnosticaron 48 pacientes seropositivos al VIH con un valor de 0.019 y 0.023 con R-R 2.9 (2.5-3.3). La intolerancia a los carbohidratos estuvo presente en cuatro pacientes, OR 1.11 (1.0-1.35). La diabetes mellitus se encontró en cuatro pacientes con OR 1.26 (1.13-1.65); y la hipertensión arterial en seis pacientes con OR 1.28 (1.11–1.62) y ORa de 1.18 (1.0-1.56). La infección por VIH, la diabetes mellitus, así como la intolerancia a los carbohidratos y la hipertensión arterial se observaron comúnmente como factores de riesgo próximos a la tuberculosis. Se recomienda la realización de estudios de esta índole con el fin de trazar estrategias para disminuir su transmisibilidad.
Descargas
Citas
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., Smith, S. C., Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, & International Association for the Study of Obesity. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation, 120(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Bagcchi, S. (2023). WHO’s global tuberculosis report 2022. The Lancet. Microbe, 4(1), e20. https://doi.org/10.1016/S2666-5247(22)00359-7
Caillon, A., & Schiffrin, E. L. (2016). Role of inflammation and immunity in hypertension: Recent epidemiological, laboratory, and clinical evidence. Current Hypertension Reports, 18(3), 21. https://doi.org/10.1007/s11906-016-0628-7
Feleke, B. E., Feleke, T. E., & Biadglegne, F. (2019). Nutritional status of tuberculosis patients, a comparative cross-sectional study. BMC Pulmonary Medicine, 19(1), 182. https://doi.org/10.1186/s12890-019-0953-0
Ferrannini, E., & Cushman, W. C. (2012). Diabetes and hypertension: the bad companions. Lancet, 380(9841), 601–610. https://doi.org/10.1016/S0140-6736(12)60987-8
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000). Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. The New England Journal of Medicine, 342(13), 905–912. https://doi.org/10.1056/NEJM200003303421301
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernández, M., O’Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., Duda, S. N., & REDCap Consortium. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95(103208), 103208. https://doi.org/10.1016/j.jbi.2019.103208
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Hensel, R. L., Kempker, R. R., Tapia, J., Oladele, A., Blumberg, H. M., & Magee, M. J. (2016). Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus. The International Journal of Tuberculosis and Lung Disease, 20(1), 71–78. https://doi.org/10.5588/ijtld.15.0457
International Diabetes Federation. (2021). International Diabetes Federation Diabetes Atlas (Tenth Edition). Belgium. https://diabetesatlas.org/
Jackson, C., Southern, J., Lalvani, A., Drobniewski, F., Griffiths, C. J., Lipman, M., Bothamley, G. H., Deeks, J. J., Imran, A., Kon, O. M., Mpofu, S., Nikolayevskyy, V., Rees-Roberts, M., Sitch, A., Sridhar, S., Tsou, C.-Y., Whitworth, H., & Abubakar, I. (2019). Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. Thorax, 74(1), 91–94. https://doi.org/10.1136/thoraxjnl-2017-211124
Jeon, C. Y., & Murray, M. B. (2008). Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine, 5(7), e152. https://doi.org/10.1371/journal.pmed.0050152
Joshi, R., Narang, U., Zwerling, A., Jain, D., Jain, V., Kalantri, S., & Pai, M. (2011). Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study. The European Respiratory Journal, 38(6), 1475–1477. https://doi.org/10.1183/09031936.00014611
Kumar, P., & Babu, S. (2017). Influence of diabetes mellitus on immunity to human tuberculosis. Immunology, 152(1), 13–24. https://doi.org/10.1111/imm.12762
Landsberg, L., & Molitch, M. (2004). Diabetes and hypertension: pathogenesis, prevention and treatment. Clinical and Experimental Hypertension, 26(7–8), 621–628. https://doi.org/10.1081/ceh-200031945
Lee, M.-R., Huang, Y.-P., Kuo, Y.-T., Luo, C.-H., Shih, Y.-J., Shu, C.-C., Wang, J.-Y., Ko, J.-C., Yu, C.-J., & Lin, H.-H. (2016). Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clinical infectious diseases, ciw836. https://doi.org/10.1093/cid/ciw836
Leung, C. C., Lam, T. H., Chan, W. M., Yew, W. W., Ho, K. S., Leung, G. M., Law, W. S., Tam, C. M., Chan, C. K., & Chang, K. C. (2008). Diabetic control and risk of tuberculosis: a cohort study. American Journal of Epidemiology, 167(12), 1486–1494. https://doi.org/10.1093/aje/kwn075
Lin, C.-H., Kuo, S.-C., Hsieh, M.-C., Ho, S.-Y., Su, I.-J., Lin, S.-H., Chi, C.-Y., Su, S.-L., Liao, C.-Y., Chen, Y.-C., Hsu, S.-R., Huang, Y.-C., Tseng, F.-C., Wang, S. Y., Dou, H. Y., Lin, S.-D., Lin, J.-S., Tu, S.-T., Yeh, Y.-P., & Changhua Research Alliance for Tuberculosis Elimination. (2019). Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open, 9(10), e029948. https://doi.org/10.1136/bmjopen-2019-029948
Marak, B., Kaur, P., Rao, S. R., & Selvaraju, S. (2016). Non-communicable disease comorbidities and risk factors among tuberculosis patients, Meghalaya, India. The Indian Journal of Tuberculosis, 63(2), 123–125. https://doi.org/10.1016/j.ijtb.2015.07.018
Martínez, L., Shen, Y., Mupere, E., Kizza, A., Hill, P. C., & Whalen, C. C. (2017). Transmission of Mycobacterium tuberculosis in households and the community: A systematic review and meta-analysis. American Journal of Epidemiology, 185(12), 1327–1339. https://doi.org/10.1093/aje/kwx025
Martínez, N., & Kornfeld, H. (2014). Diabetes and immunity to tuberculosis: Highlights. European Journal of Immunology, 44(3), 617–626. https://doi.org/10.1002/eji.201344301
Nyirenda, J. L. Z., Bockey, A., Wagner, D., & Lange, B. (2023). Effect of Tuberculosis (TB) and Diabetes mellitus (DM) integrated healthcare on bidirectional screening and treatment outcomes among TB patients and people living with DM in developing countries: a systematic review. Pathogens and global health, 117(1), 36–51. https://doi.org/10.1080/20477724.2022.2046967
Pedditzi E, Peters R, Beckett N. (2016). The risk of overweight/obesity in midlife and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Aging, 45, 14–21. https://acortar.link/rXZFoU
Seegert, A. B., Rudolf, F., Wejse, C., & Neupane, D. (2017). Tuberculosis and hypertension-a systematic review of the literature. International Journal of Infectious Diseases, 56, 54–61. https://doi.org/10.1016/j.ijid.2016.12.016
Solá, E., Rivera, C., Mangual, M., Martinez, J., Rivera, K., & Fernandez, R. (2016). Diabetes mellitus: an important risk factor for reactivation of tuberculosis. Endocrinology, Diabetes & Metabolism Case Reports, 2016. https://doi.org/10.1530/EDM-16-0035
Verver, S., Warren, R. M., Munch, Z., Richardson, M., van der Spuy, G. D., Borgdorff, M. W., Behr, M. A., Beyers, N., & van Helden, P. D. (2004). Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet, 363(9404), 212–214. https://doi.org/10.1016/S0140-6736(03)15332-9
World Health Organization. (2021, octubre 14). Global tuberculosis report 2021. Who.int; World Health Organization. https://www.who.int/publications/i/item/9789240037021
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Juan Camilo Martínez, Juan Sebastián Theran Leon, Jaime Gómez, Valentina Cabrera Peña, Rafael Guillermo Parales Strauch, Edgar Camilo Blanco Pimiento, María Paula Ciliberti Artavia, Luis Andres Dulcey Sarmiento, Juan Camilo Mayorca, María Alejandra Cala
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
